A Cost-Utility Analysis of Misoprostol Prophylaxis for Rheumatoid Arthritis Patients Receiving Nonsteroidal Antiinflammatory Drugs

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Antiinflammatory Drugs ◽

Misoprostol Prophylaxis

Comment on the article “Comparison of the Cost-Utility Analysis of Electroacupuncture and Nonsteroidal Antiinflammatory Drugs in the Treatment of Chronic Low Back Pain”

Journal of Acupuncture and Meridian Studies ◽

10.1016/j.jams.2018.11.004 ◽

2018 ◽

Vol 11 (6) ◽

pp. 341-342

Author(s):

Zumi Mehta ◽

Margaret English ◽

Cecelia Trybus ◽

Valerie Magda ◽

Khalid Kamal

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Cost Utility ◽

Cost Utility Analysis ◽

Low Back ◽

Utility Analysis ◽

Antiinflammatory Drugs ◽

The Cost

Response to the Article “Comparison of the Cost-Utility Analysis of Electroacupuncture and Nonsteroidal Antiinflammatory Drugs in the Treatment of Chronic Low Back Pain”

Journal of Acupuncture and Meridian Studies ◽

10.1016/j.jams.2019.02.001 ◽

2019 ◽

Vol 12 (1) ◽

pp. 1-2

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Cost Utility ◽

Cost Utility Analysis ◽

Low Back ◽

Utility Analysis ◽

Antiinflammatory Drugs ◽

The Cost

Comparison of the Cost-utility Analysis of Electroacupuncture and Nonsteroidal Antiinflammatory Drugs in the Treatment of Chronic Low Back Pain

Journal of Acupuncture and Meridian Studies ◽

10.1016/j.jams.2018.01.003 ◽

2018 ◽

Vol 11 (2) ◽

pp. 62-66 ◽

Cited By ~ 5

Author(s):

Mahdi Toroski ◽

Shekoufeh Nikfar ◽

Mohammad Mahdi Mojahedian ◽

Mohammad Hosein Ayati

Keyword(s):

Low Back Pain ◽

Back Pain ◽

Chronic Low Back Pain ◽

Cost Utility ◽

Cost Utility Analysis ◽

Low Back ◽

Utility Analysis ◽

Antiinflammatory Drugs ◽

The Cost

Cost-utility analysis of certolizumab pegol in combination with methotrexate in patients with moderate-to-severe active rheumatoid arthritis in Greece

Rheumatology International ◽

10.1007/s00296-017-3736-z ◽

2017 ◽

Vol 37 (9) ◽

pp. 1441-1452 ◽

Cited By ~ 2

Author(s):

C. Tzanetakos ◽

A. Tzioufas ◽

A. Goules ◽

G. Kourlaba ◽

T. Theodoratou ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Certolizumab Pegol ◽

Cost Utility ◽

Cost Utility Analysis ◽

Cost-Utility Analysis of Tocilizumab in Combination with Methotrexate Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

Value in Health ◽

10.1016/j.jval.2013.08.1505 ◽

2013 ◽

Vol 16 (7) ◽

pp. A565

Author(s):

K. Athanasakis ◽

T. Konstantopoulou ◽

F. Tarantilis ◽

K. Tsalapati ◽

E. Vritzali ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Standard Of Care ◽

Cost Utility ◽

Cost Utility Analysis ◽

PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA

Value in Health ◽

10.1016/s1098-3015(10)63265-2 ◽

2006 ◽

Vol 9 (6) ◽

pp. A222

Author(s):

B Mistry ◽

J McCormick ◽

A Diamantopoulos ◽

A Kielhorn

Keyword(s):

Rheumatoid Arthritis ◽

Therapeutic Option ◽

Cost Utility ◽

Cost Utility Analysis ◽

Disease Modifying Antirheumatic Drug

UK cost-utility analysis of rituximab in patients with rheumatoid arthritis that failed to respond adequately to a biologic disease-modifying antirheumatic drug

Current Medical Research and Opinion ◽

10.1185/03007990802321683 ◽

2008 ◽

Vol 24 (9) ◽

pp. 2639-2650 ◽

Cited By ~ 35

Author(s):

Adrian Kielhorn ◽

Duncan Porter ◽

Alexander Diamantopoulos ◽

Gavin Lewis

Keyword(s):

Rheumatoid Arthritis ◽

Cost Utility ◽

Cost Utility Analysis ◽

Antirheumatic Drug ◽

Utility Analysis ◽

Disease Modifying ◽

FRI0155 Long-term cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis – 5 year follow-up data from the best study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.2612 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 363.2-364 ◽

Cited By ~ 1

Author(s):

W. van den Hout ◽

N. Klarenbeek ◽

L. Dirven ◽

P. Kerstens ◽

T. Huizinga ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Treatment Strategies ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Recent Onset

Cost-Utility Analysis of Tocilizumab Monotherapy Versus Standard of Care for the Treatment of Rheumatoid Arthritis in Greece

Value in Health ◽

10.1016/j.jval.2013.08.1503 ◽

2013 ◽

Vol 16 (7) ◽

pp. A565

Author(s):

K. Athanasakis ◽

T. Konstantopoulou ◽

F. Tarantilis ◽

K. Tsalapati ◽

E. Vritzali ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Standard Of Care ◽

Cost Utility ◽

Cost Utility Analysis ◽

Utility Analysis ◽

Tocilizumab Monotherapy

OP0116 Cost-effectiveness and cost-utility analysis of treat-to-target versus usual care in early rheumatoid arthritis: Results of the dream registry

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2012-eular.1799 ◽

2013 ◽

Vol 71 (Suppl 3) ◽

pp. 92.2-92

Author(s):

M. Vermeer ◽

W. Kievit ◽

I. Kuper ◽

A. Braakman-Jansen ◽

H. Bernelot Moens ◽

...

Keyword(s):

Rheumatoid Arthritis ◽

Cost Effectiveness ◽

Usual Care ◽

Early Rheumatoid Arthritis ◽

Cost Utility ◽

Cost Utility Analysis ◽

Treat To Target ◽